Results 111 to 120 of about 39,253,262 (150)
Some of the next articles are maybe not open access.
CNS and Neurological Disorders - Drug Targets, 2021
Background: A dimeric dipeptide mimetic of the BDNF loop 4, bis(N-monosuccinyl- L-seryl-L-lysine) hexamethylenediamide (GSB-106) activates TrkB, PI3K/AKT, MAPK/ ERK, and PLC-γ1, and was created at the V.V. Zakusov Research Institute of Pharmacology. GSB-106 showed neuroprotective activity in vitro and in vivo at systemic administration.
Tatiana A Gudasheva +2 more
exaly +3 more sources
Background: A dimeric dipeptide mimetic of the BDNF loop 4, bis(N-monosuccinyl- L-seryl-L-lysine) hexamethylenediamide (GSB-106) activates TrkB, PI3K/AKT, MAPK/ ERK, and PLC-γ1, and was created at the V.V. Zakusov Research Institute of Pharmacology. GSB-106 showed neuroprotective activity in vitro and in vivo at systemic administration.
Tatiana A Gudasheva +2 more
exaly +3 more sources
Pharmaceutical Chemistry Journal, 2019
Studies at the V. V. Zakusov Science Research Institute of Pharmacology have worked on the basis of the β-pleated structure of loop 4 of brain-derived neurotrophic factor (BDNF) to construct its dimeric peptide mimetic - GSB-106, bis-(N-monosuccinyl-L-serine-L-lysine) hexamethylenediamide.
Nellya M Sazonova, A V Tarasyuk
exaly +2 more sources
Studies at the V. V. Zakusov Science Research Institute of Pharmacology have worked on the basis of the β-pleated structure of loop 4 of brain-derived neurotrophic factor (BDNF) to construct its dimeric peptide mimetic - GSB-106, bis-(N-monosuccinyl-L-serine-L-lysine) hexamethylenediamide.
Nellya M Sazonova, A V Tarasyuk
exaly +2 more sources
Doklady Biochemistry and Biophysics, 2023
Using TrkA or TrkB receptor gene knockout HT-22 cells showed the selectivity of the interaction of the low molecular weight dipeptide BDNF mimetic GSB-106 (hexamethylenediamide bis(N-monosuccinyl-L-seryl-L-lysine)) with TrkB receptors.
I O Logvinov +2 more
exaly +3 more sources
Using TrkA or TrkB receptor gene knockout HT-22 cells showed the selectivity of the interaction of the low molecular weight dipeptide BDNF mimetic GSB-106 (hexamethylenediamide bis(N-monosuccinyl-L-seryl-L-lysine)) with TrkB receptors.
I O Logvinov +2 more
exaly +3 more sources
Dipeptide Mimetic of the BDNF GSB-106 with Antidepressant-Like Activity Stimulates Synaptogenesis
Доклады академии наук, 2018Dipeptide mimetic of the brain-derived neurotrophic factor bis(N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide (working name GSB-106), which reproduces the homodimeric structure of BDNF and the beta-turn of its fourth loop, activates TrkB, AKT, and ERK, exhibits neuroprotective and antidepressant activity, and is able to stimulate neurogenesis in
T A, Gudasheva +3 more
+6 more sources
Bulletin of Experimental Biology and Medicine, 2013
Dimeric dipeptide GSB-106, a novel structural analogue of neurotrophin BDNF, in doses from 10(-5) to 10(-8) M protected cultured immortalized mouse hippocampal HT-22 neurons from H2O2 or glutamate damage. The neuroprotective effect of GSB-106 was also shown on cultured SH-SY5Y human neuroblastoma cells after treatment with neurotoxin 6-hydroxidopamine.
Sergei B Seredenin +2 more
exaly +3 more sources
Dimeric dipeptide GSB-106, a novel structural analogue of neurotrophin BDNF, in doses from 10(-5) to 10(-8) M protected cultured immortalized mouse hippocampal HT-22 neurons from H2O2 or glutamate damage. The neuroprotective effect of GSB-106 was also shown on cultured SH-SY5Y human neuroblastoma cells after treatment with neurotoxin 6-hydroxidopamine.
Sergei B Seredenin +2 more
exaly +3 more sources
Synthesis of BDNF-mimetic dimeric dipeptide GSB-106, a potential neuroprotector drug
Pharmaceutical Chemistry Journal, 2013The BDNF-mimetic dimeric dipeptide bis-(N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide (GSB-106) based on the structure of beta-turn loop 4 (BDNF-Asp93-Ser94-Lys95-Lys96-) was synthesized. GSB-106 showed neuroprotective activity in vitro at concentrations 10–6-10–8 M and antidepressant activity in vivo in rats at i.p.
A. V. Tarasyuk +3 more
openaire +1 more source
Pharmaceutical Chemistry Journal, 2021
Antidepressant activities of the original compounds GSB-106 [bis(N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide], a mimetic of the fourth loop of brain-derived neurotrophic factor (BDNF); GML-3(N-butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide), a ligand of 18 kDa translocator protein (TSPO); and GZK-111 (N-phenylacetylglycyl-L ...
A. V. Tallerova +4 more
openaire +1 more source
Antidepressant activities of the original compounds GSB-106 [bis(N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide], a mimetic of the fourth loop of brain-derived neurotrophic factor (BDNF); GML-3(N-butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide), a ligand of 18 kDa translocator protein (TSPO); and GZK-111 (N-phenylacetylglycyl-L ...
A. V. Tallerova +4 more
openaire +1 more source
Low-Molecular-Weight Compound GSB-106 Mimics the Cellular Effects of BDNF after Serum Deprivation
Doklady Biochemistry and Biophysics, 2019The in vitro model of serum deprivation shows that the survival of SH-SY5Y neuronal cells is ensured by the intrinsic trophic activity of BDNF loop 4-th mimetic GSB‑106 (10-7 М), which is comparable to that of endogenous neurotrophin (10-9 М). The analysis of the cell cycle and S‑phase showed that GSB‑106, like BDNF, induces cell cycle arrest in the G1
L F, Zainullina +3 more
openaire +2 more sources
Journal of Clinical Physiology and Pathology, 2023
Relevance. At the V.V. Zakusov Research Institute of Pharmacology. Zakusov dimeric dipeptide mimetics of nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF), GK-2 and GSB-106, respectively, were created. GK-2 and GSS-106 were found to be similar to the corresponding full-length neurotrophinsin their mechanism of action and ...
A. Inozemtsev +4 more
openaire +1 more source
Relevance. At the V.V. Zakusov Research Institute of Pharmacology. Zakusov dimeric dipeptide mimetics of nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF), GK-2 and GSB-106, respectively, were created. GK-2 and GSS-106 were found to be similar to the corresponding full-length neurotrophinsin their mechanism of action and ...
A. Inozemtsev +4 more
openaire +1 more source
Russian Journal of Bioorganic Chemistry, 2014
In the previous work, we synthesized a dimeric dipeptide mimetic of the 4th loop of BDNF, i.e., hexamethylenediamide bis(N-monosuccinil-L-seryl-L-lysine) (GSB-106), which has neuroprotective activity in vitro in a concentration range of 10−5–10−8 M and antidepressant activity in vivo at intraperitoneal doses of 0.1 and 1 mg/kg in rats.
A. V. Tarasyuk +8 more
openaire +1 more source
In the previous work, we synthesized a dimeric dipeptide mimetic of the 4th loop of BDNF, i.e., hexamethylenediamide bis(N-monosuccinil-L-seryl-L-lysine) (GSB-106), which has neuroprotective activity in vitro in a concentration range of 10−5–10−8 M and antidepressant activity in vivo at intraperitoneal doses of 0.1 and 1 mg/kg in rats.
A. V. Tarasyuk +8 more
openaire +1 more source

